Stocks
Monte Rosa Therapeutics, Inc.GLUE
NASDAQHealthcareBiotechnology$10.84
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted protein degradation therapies, specifically molecular glue degraders, for difficult-to-treat cancers and other diseases. Its lead programs focus on CDK2 and GSPT1 targets, with early clinical data drawing investor attention in the precision oncology space.
52W Range: $9.68-$25.77
Congressional Interest in Monte Rosa Therapeutics, Inc. (GLUE)
No congressional trades have been disclosed for Monte Rosa Therapeutics, Inc. (GLUE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading GLUE?
No congressional trades found for this stock.